Related Experiment Video
Updated: Mar 25, 2026
10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
37.1K
Ebola vaccine and treatment
1Hokkaido University Research Center for Zoonosis Control.
Uirusu
|March 1, 2016
Summary
No approved vaccines or treatments exist for filovirus diseases like Ebola. This review covers the latest research and developments in Ebola virus disease vaccines and therapies, spurred by recent outbreaks.
Area of Science:
- Virology
- Infectious Diseases
- Public Health
Background:
- Filoviruses, including Ebola and Marburg viruses, are responsible for severe hemorrhagic fevers.
- Currently, no commercially available prophylaxis or treatment exists for filovirus diseases.
- Recent Ebola virus disease outbreaks have intensified research into effective interventions.
Purpose of the Study:
- To review existing research on filovirus vaccines and therapies.
- To discuss the latest advancements in the development of anti-Ebola virus prophylaxis and treatment.
Main Methods:
- Literature review of previous research.
- Analysis of recent studies and clinical trial data.
- Synthesis of current knowledge on vaccine and therapy development for Ebola virus disease.
Main Results:
- The review covers a range of vaccine candidates and therapeutic strategies.
- Unapproved drugs were utilized during the West Africa outbreak, providing preliminary data.
- Significant progress has been made in developing potential countermeasures.
Conclusions:
- Accelerated efforts are yielding promising vaccine and therapy options for Ebola virus disease.
- Continued research is crucial to provide effective prophylaxis and treatment against filoviruses.
Related Concept Videos
00:42Cross-reactivity
33.8K
Overview
33.8K
01:28Pulmonary Tuberculosis V
761
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
761
01:26Pharmaceutical Poisoning: Treatment Strategies
147
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
147
01:51Vaccinations
53.5K
Overview
53.5K
01:23Vaccine Production
33
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
33
01:28Pneumonia IV: Management
1.0K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.0K